Vitiligo can affect several structures of the eye, not just the skin around it. The same autoimmune process that destroys melanocytes in the skin also targets pigment-producing cells in the iris, choroid, and retinal pigment epithelium, sometimes producing measurable changes even when a person has no visual complaints. Most of these changes are subtle and picked up only on specialized imaging, but they deserve attention because a small fraction of people with vitiligo develop clinically meaningful eye problems.
What You Might Notice on the Outside
The most visible sign of vitiligo around the eyes is depigmentation of the eyelid skin. White or light patches on or near the eyelids follow the same pattern as vitiligo elsewhere on the face. In some cases, the loss of melanocytes extends into the hair follicles of the lashes, turning them white, a feature called leukotrichia. A case report described a child with segmental vitiligo involving the eyelid margin and adjacent whitened eyelashes, which is characteristic of periorbital vitiligo that reaches the lash line.1PubMed Central. Segmental vitiligo of the lid margin with leukotrichia of lashes in a child Periorbital vitiligo is particularly common because the face is one of the sites most frequently affected by the condition overall.
White eyelashes or a patch of pale skin along the lid can be the first sign that prompts someone to seek a diagnosis. The cosmetic impact tends to be significant because the eyes are the focal point of the face. For some people the outer changes are the only eye-related effect they ever experience. For others, though, there are changes happening inside the eye that they cannot see or feel.
Pigment Loss Inside the Eye
Inside the eye, melanocytes are concentrated in several layers: the iris (which gives the eye its color), the choroid (a vascular layer behind the retina), and the retinal pigment epithelium, or RPE, a thin sheet of pigmented cells that supports the light-sensing photoreceptors. A systematic review of the available research found that pigmentary abnormalities of various ocular structures, especially the RPE, represent one of the strongest links between vitiligo and eye pathology.2PubMed Central. Ocular manifestations of vitiligo: a systematic review
What does this look like in practice? Eye exams using specialized cameras and scans have revealed hypopigmented patches in the retina and choroid, along with irregularities in the RPE. Advanced imaging has shown thinning of the retinal nerve fiber layer and reduced choroidal thickness in people with vitiligo compared to people without it, pointing toward subtle, subclinical retinal degeneration. One research group reported structural changes in the retina of vitiligo patients, including thinning of the photoreceptor layer and RPE atrophy, even when those individuals had no visual symptoms at all.3PubMed Central. Retinal Vulnerability to Light Pollution in Vitiligo: A Narrative Review of the Role of Melanin Loss in Ocular Phototoxicity
The word “subclinical” is key here. Many of these findings are detectable only with optical coherence tomography (OCT), a type of high-resolution eye scan, or with fundoscopy, where a doctor looks at the back of the eye through a dilated pupil. The person sitting in the chair usually feels fine and sees normally. That gap between measurable changes and actual symptoms is one of the reasons ocular involvement in vitiligo has historically been under-recognized.
Dry Eye Disease
Of all the eye conditions linked to vitiligo, dry eye disease has one of the most consistent associations. The same systematic review that highlighted RPE abnormalities found that dry eye was among the strongest connections between vitiligo and ocular pathology.2PubMed Central. Ocular manifestations of vitiligo: a systematic review The mechanism is not entirely settled, but it likely involves a combination of factors. Melanocytes are present in the lacrimal glands and in the conjunctiva, the thin membrane covering the white of the eye. If the autoimmune process damages melanocytes there, it could disrupt the tear film or the ocular surface in ways that promote dryness and irritation.
From a practical standpoint, if you have vitiligo and your eyes often feel gritty, scratchy, or watery (watery eyes can paradoxically be a symptom of dry eye, because the eye tries to compensate with reflex tears), it is worth mentioning vitiligo to your eye doctor. They can test your tear film and, if needed, recommend lubricating drops or other treatments. Dry eye is manageable for most people, but it is more comfortable to manage when you catch it early rather than after chronic irritation has set in.
The Uveitis Connection
Uveitis is inflammation inside the eye, and its relationship to vitiligo has been debated. A large population-based study of more than 24,000 vitiligo patients and over 114,000 controls found that the odds of having uveitis were about 35 percent higher in the vitiligo group. That association held up even after accounting for other conditions known to cause uveitis, like inflammatory bowel disease and sarcoidosis.4International Journal of Dermatology. The Association Between Vitiligo and Uveitis: A Large Population-Based Study A smaller study of 92 vitiligo patients found ocular abnormalities in roughly one in five, with uveitis being the most common individual finding in that group.5Journal of Skin and Stem Cell. Prevalence of Ocular Findings in Patients with Vitiligo
Interestingly, the systematic review mentioned earlier did not find conclusive evidence for an increased risk of uveitis in the vitiligo population overall.2PubMed Central. Ocular manifestations of vitiligo: a systematic review This tension in the literature is not unusual. The studies that look for uveitis use different methods, different populations, and different definitions of what counts as uveitis. What seems fair to say is that the risk, if elevated, is modest in absolute terms. In the large population study, the overall prevalence of uveitis was under one percent even in the vitiligo group. So while the relative increase is real, most people with vitiligo will never develop uveitis. Symptoms to watch for include eye pain, redness, light sensitivity, and floaters. If those develop, getting checked promptly matters because untreated uveitis can damage vision.
Vogt-Koyanagi-Harada Syndrome
One condition worth knowing about, even though it is uncommon, is Vogt-Koyanagi-Harada syndrome, often abbreviated VKH. This is a distinct autoimmune condition in which the immune system attacks melanocytes throughout the body, causing inflammation in both eyes (bilateral granulomatous uveitis), along with skin depigmentation that resembles vitiligo, whitening of hair or lashes, patchy hair loss, and sometimes neurological or hearing symptoms.6PubMed. Vogt-Koyanagi-Harada syndrome It appears to be driven by an immune response directed against melanocytes, influenced by genetic factors. There is even evidence that the syndrome can be triggered by skin injury, supporting the idea that exposing melanocyte proteins to the immune system can set off a bodywide response.7PubMed. Vogt-Koyanagi-Harada syndrome after cutaneous injury
VKH is not the same disease as vitiligo, but the two share enough immune machinery that they overlap in clinical discussions. If someone with vitiligo develops sudden bilateral eye inflammation, headaches, hearing changes, or rapid spread of skin depigmentation, VKH should be on the differential. Early treatment with immunosuppressive therapy is important for preserving vision in VKH, whereas ordinary vitiligo alone rarely threatens eyesight. Understanding the distinction helps you know when symptoms are routine and when they signal something more urgent.
Choroidal Vitiligo and How Doctors See It
A relatively newer concept in the literature is “choroidal vitiligo,” where the depigmentation occurs specifically in the choroid, the pigmented vascular layer just behind the retina. A systematic review of imaging findings in choroidal vitiligo described a consistent pattern: well-defined areas of choroidal hypopigmentation with intact retinal architecture and no sign of active inflammation. OCT scans showed that the retinal layers themselves were preserved, with only occasional mild thinning of the choroid. Another imaging technique, fundus autofluorescence, often showed increased brightness in the affected areas because the sclera (the white outer coat of the eye) was showing through where choroidal pigment was missing. Fluorescein angiography showed mild “window defects,” basically light leaking through thinner pigment, but no leakage of fluid, which is a reassuring sign that no active inflammatory damage is occurring.8PubMed. Choroidal vitiligo: systematic review of imaging findings, clinical presentation, and diagnostic considerations
This imaging profile is clinically useful because it helps doctors distinguish choroidal vitiligo from other conditions that can cause pale patches in the back of the eye, including inflammatory chorioretinitis, white dot syndromes, and infections. In one case series, patients with herpes zoster virus affecting the eye developed multiple hypopigmented choroidal lesions that looked similar on examination, but the clinical context (a history of shingles rash on the forehead, corneal inflammation, and changes confined to one eye) pointed to a viral cause rather than autoimmune depigmentation.9Ocular Immunology and Inflammation. Viral Kerato-Uveitis with Choroidal Vitiligo In vitiligo, the choroidal changes are typically bilateral and are not accompanied by signs of active inflammation, which is the key distinguishing feature.
Does Any of This Affect Vision?
For the vast majority of people with vitiligo, the answer is no. The pigmentary changes in the retina and choroid are usually mild enough that they do not impair day-to-day vision. Photoreceptor function may be subtly altered in some individuals, but this tends to show up on specialized testing rather than in how well you can read or drive.
There are exceptions. If vitiligo-related melanocyte loss in the RPE becomes severe, it could theoretically compromise the support system for photoreceptors and lead to gradual visual changes, but this has not been documented as a common outcome. The more concrete threat to vision comes from associated conditions rather than from pigment loss itself. Uveitis, if it develops and goes untreated, can cause scarring, elevated eye pressure, and vision loss. VKH can cause retinal detachments and significant visual impairment if not treated aggressively. The systematic review also flagged normal-tension glaucoma as potentially more prevalent in vitiligo, although that evidence is still tentative.2PubMed Central. Ocular manifestations of vitiligo: a systematic review
The practical takeaway is straightforward. If you have vitiligo, periodic eye exams with a dilated fundoscopic evaluation are a reasonable precaution. Many dermatologists do not routinely refer vitiligo patients for eye screenings, and many eye doctors do not ask about skin conditions, so you may need to be the one who connects the dots. An annual or biannual dilated eye exam is sufficient for most people. If you develop any eye symptoms like pain, redness, blurred vision, or increased light sensitivity, move that appointment up.
The Role of Melanin in Protecting the Eye
One reason researchers care about melanocyte loss in the eye is that ocular melanin is not just decorative. In the RPE and choroid, melanin absorbs stray light, reduces oxidative stress, and helps protect the photoreceptors from phototoxic damage. When that pigment is reduced or absent, the retina may be more vulnerable to light-induced injury. A narrative review specifically examined this possibility, arguing that vitiligo patients with reduced ocular melanin could face heightened susceptibility to damage from ambient light, including artificial light exposure at night.3PubMed Central. Retinal Vulnerability to Light Pollution in Vitiligo: A Narrative Review of the Role of Melanin Loss in Ocular Phototoxicity
Whether this translates into practical advice beyond standard eye-health recommendations is still unclear. Wearing UV-blocking sunglasses outdoors is already universally recommended, but it may carry extra weight for people whose retinal pigment layer is thinner than average. The idea that melanin loss makes the eye more susceptible to everyday light exposure is biologically plausible and supported by the structural changes seen on imaging, but no one has yet shown that vitiligo patients develop accelerated retinal degeneration from normal light exposure at a rate that would change clinical management. It is a question the field is watching.
Living with Facial Vitiligo
Even when ocular involvement is medically mild, the psychological impact of vitiligo around the eyes and face can be significant. A comprehensive review of quality-of-life studies found that vitiligo consistently impairs psychological and social well-being, and that facial involvement is one of the strongest predictors of worse outcomes. Depression and anxiety were more frequently reported in people with vitiligo than in the general population, with younger patients being particularly vulnerable.10PubMed Central. Quality of life impairment in vitiligo: A comprehensive review of psychosocial and clinical determinants A study from Japan found that roughly six in ten vitiligo patients reported at least some effect on their daily lives, and about four in ten met screening thresholds for possible anxiety or depression.11PubMed Central. Health-Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan
Periorbital vitiligo is especially hard to conceal with cosmetics because the skin around the eyes is thin and the eyelids are mobile, so makeup tends to crease and transfer. Leukotrichia of the lashes is essentially impossible to hide. For people who are self-conscious about these features, the emotional toll can be substantial regardless of whether any internal eye changes are present. Connecting with support communities, working with a therapist experienced in body-image concerns, and exploring treatment options for facial repigmentation are all reasonable steps.
Where Treatment Stands
Current vitiligo treatments focus on the skin. The most common approaches include topical corticosteroids, topical calcineurin inhibitors (tacrolimus, pimecrolimus), and narrowband UVB phototherapy. The face and neck tend to respond better to treatment than the hands and feet, which is encouraging news for people with periorbital involvement.
A newer class of drugs, topical JAK inhibitors, has shown promise specifically for facial vitiligo. A meta-analysis of randomized controlled trials found that patients treated with a topical JAK inhibitor were substantially more likely to achieve significant facial repigmentation than those using a placebo cream. Across single-arm trials, the average improvement in vitiligo area was about 44 percent, and combining JAK inhibitors with narrowband UVB pushed repigmentation rates even higher.12PubMed Central. Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis The topical JAK inhibitor ruxolitinib (brand name Opzelura) is now approved in several countries for facial vitiligo in adults.
What none of these treatments do, at least so far, is target ocular melanocyte loss. Topical creams obviously cannot reach the choroid or RPE, and systemic JAK inhibitors, while being studied for widespread vitiligo, have not been evaluated for their effect on ocular pigmentation. If the autoimmune damage to ocular melanocytes mirrors what happens in the skin, it is reasonable to hypothesize that systemic immune modulation might slow or prevent ocular pigment loss as well, but that remains speculative. For now, managing eye-related issues means monitoring for them and treating complications like dry eye or uveitis individually as they arise.
Light-Eyed vs. Dark-Eyed Individuals
One question that comes up is whether baseline eye color matters. People with darker irises have more melanin in the iris stroma, while those with lighter eyes have less to begin with. In theory, someone who starts with more ocular pigment has more to lose before reaching a threshold where function is affected. Conversely, people with very light eyes already have relatively low levels of protective melanin, so any additional loss from vitiligo might have proportionally less impact on the measurable difference between their baseline and the vitiligo state.
The research has not cleanly resolved this. Most studies of ocular findings in vitiligo have been done in populations with moderate to heavy baseline pigmentation, which means the depigmented patches in the choroid and RPE are easier to spot on imaging against a darker background. In people with light eyes and light fundi, subtle choroidal vitiligo could be harder to detect simply because there is less contrast. This is a limitation in the current literature rather than evidence that lighter-eyed individuals are unaffected. If you have vitiligo and light-colored eyes, the same advice applies: periodic dilated eye exams and attention to any new visual symptoms.